Filing Details
- Accession Number:
- 0000899243-16-023868
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-29 18:14:54
- Reporting Period:
- 2016-06-27
- Filing Date:
- 2016-06-29
- Accepted Time:
- 2016-06-29 18:14:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1453687 | Selecta Biosciences Inc | SELB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1548606 | Rusnano | 10A Prospect 60-Letiya Oktyabrya Moscow 1Z 117036 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-06-27 | 107,143 | $14.00 | 157,009 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-06-27 | 799,915 | $0.00 | 956,924 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2016-06-27 | 208,705 | $0.00 | 1,165,629 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2016-06-27 | 310,548 | $0.00 | 1,476,177 | No | 4 | C | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series D Convertible Preferred Stock | Disposition | 2016-06-27 | 2,981,019 | $0.00 | 799,915 | $0.00 |
| Common Stock | Series SRN Convertible Preferred Stock | Disposition | 2016-06-27 | 777,777 | $0.00 | 208,705 | $0.00 |
| Common Stock | Series E Convertible Preferred Stock | Disposition | 2016-06-27 | 781,322 | $0.00 | 310,548 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- 2,981,019 outstanding shares of Series D Convertible Preferred Stock automatically converted into 799,915 shares of Common Stock upon the closing of the Issuer's initial public offering of Common Stock and had no expiration date.
- 777,777 outstanding shares of Series SRN Convertible Preferred Stock automatically converted into 208,705 shares of Common Stock upon the closing of the Issuer's initial public offering of Common Stock and had no expiration date.
- 781,322 outstanding shares of Series E Convertible Preferred Stock automatically converted into 310,548 shares of Common Stock upon the closing of the Issuer's initial public offering of Common Stock and had no expiration date.
Billionaire Hedge Funds
